Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RNN

Rexahn

$6.82

1.33 (24.23%)

12:57
04/16/19
04/16
12:57
04/16/19
12:57
Hot Stocks
Rexahn soars after finding Chinese partner for cancer drug RX-3117 »

Rexahn Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
RNN

Rexahn

$0.58

-0.004 (-0.68%)

16:09
04/10/19
04/10
16:09
04/10/19
16:09
Hot Stocks
Rexahn annouces 1-for-12 reverse stock split »

Rexahn Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
RNN

Rexahn

$0.52

0.0071 (1.37%)

08:03
03/04/19
03/04
08:03
03/04/19
08:03
Hot Stocks
Rexahn reports target enrollment reached in Phase 2a RX-3117, Abraxane trial »

Rexahn Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

RNN

Rexahn

$0.63

-0.019 (-2.95%)

07:41
02/05/19
02/05
07:41
02/05/19
07:41
Recommendations
Rexahn analyst commentary at H.C. Wainwright »

Rexahn price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNN

Rexahn

$1.01

-0.22 (-17.89%)

08:50
01/23/19
01/23
08:50
01/23/19
08:50
Syndicate
Rexahn 10.75M share Spot Secondary priced at 80c »

Oppenheimer acted as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

RNN

Rexahn

$1.01

-0.22 (-17.89%)

16:42
01/22/19
01/22
16:42
01/22/19
16:42
Syndicate
Rexahn files to sell common stock and warrants, no amount given »

Oppenheimer & Co. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
RNN

Rexahn

$1.10

0.005 (0.46%)

12:16
12/06/18
12/06
12:16
12/06/18
12:16
Recommendations
Rexahn analyst commentary at H.C. Wainwright »

Rexahn focusing on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNN

Rexahn

$1.10

0.005 (0.46%)

, MRK

Merck

$76.46

-1.82 (-2.33%)

12:09
12/06/18
12/06
12:09
12/06/18
12:09
Hot Stocks
Rexahn updates estimated date of first enrollment in TNBC trial »

Rexahn (RNN) is updating…

RNN

Rexahn

$1.10

0.005 (0.46%)

MRK

Merck

$76.46

-1.82 (-2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jan

  • 16

    Feb

RNN

Rexahn

$1.10

0.005 (0.46%)

12:06
12/06/18
12/06
12:06
12/06/18
12:06
Hot Stocks
Rexahn sees Phase 2 RX-3117 study in advanced bladder cancer data next year »

Rexahn Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNN

Rexahn

$1.10

0.005 (0.46%)

12:05
12/06/18
12/06
12:05
12/06/18
12:05
Hot Stocks
Rexahn announces operational restructuring, workforce reductions »

Rexahn Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.